Neurodegenerative diseases are characterized by overwhelming inflammation and limited healing capacity within the central nervous system (CNS). In a healthy body, the immune system initiates inflammation to combat pathogens, but in neurodegenerative conditions, this response becomes destructive. The immune system infiltrates the CNS, damaging tissues and causing irreversible harm due to the CNS's restricted ability to repair itself. Despite advancements in medicine extending life expectancy, there are still no cures for these debilitating diseases, and current treatments offer minimal solutions to halt disease progression.

Mesenchymal Stem Cells (MSCs) offer a groundbreaking alternative for neurodegenerative care. These remarkable cells secrete growth factors, including cytokines, that promote neural healing and repair. MSCs enhance the CNS's limited healing responses, offering relief to damaged tissue and even slowing or halting disease progression. Patients treated with MSCs have shown significant improvements in healthspan and quality of life.

What sets MSCs apart is their unparalleled ability to modulate the immune system. By reducing systemic inflammation and restoring immune balance, MSCs help the body regain control, minimize pain, and improve overall condition. This innovative therapy represents a new frontier in treating neurodegenerative diseases, offering hope where standard medical care has fallen short.